Growth performance and mammary gland development of Holstein calves fed milk with 15% solids and treated with growth promoters.

The objective of this study was to evaluate growth performance, and mammary gland parenchyma (PAR) development in Holstein female calves fed whole milk combined with milk replacer for 15% total solids (15TS) or only milk (11% TS; 11TS). The effects of zilpaterol hydrochloride (ZH) and an estrogenic implant (EI) on growth performance, serum metabolites, and PAR development in post-weaning calves (63-90 days of age) fed 15TS or 11TS were also investigated. In the first phase, 78 calves were randomly divided into two groups (n = 39/group), 15TS, or 11TS (5 to 8 L/day; starter ad libitum). After weaning, calves were randomly assigned to four treatments, no EI, EI, ZH, and ZH-EI. In phase 1, 15TS calves had greater (P < 0.01) average body weight at weaning than 11TS calves (82.0 ± 5.8 vs. 74.1 ± 5.7 kg). Pre-weaning average daily gain (718 ± 67 vs. 576 ± 64 g/day) was higher (P < 0.01) for 15TS calves than 11TS calves. Feed/gain (1.5 ± 0.3 vs. 1.8 ± 0.3 kg of DMI/kg of gain) was lower (P < 0.01) for 15TS calves than 11TS calves. PAR area (8.8 ± 3.3 vs. 5.0 ± 1.6 cm) was greater (P < 0.01) for 15TS calves than 11TS calves. No differences (P > 0.10) in average daily gain (986 ± 79 g/day across treatments) were observed in calves receiving ZH, EI, or ZH-EI fed 15TS or 11TS diets previously. However, the PAR area of 15TS calves administered ZH-EI was 2.2 times greater (P < 0.01) than 11TS calves with no ZH and CI. This study demonstrated the benefits of supplying milk with 15% TS for enhancing overall animal growth and PAR development. Further use of ZH and EI during the post-weaning period did improve mammary PAR growth.